Flu prevention drugs for hospital patients and caregivers
Treatments studied
Part of Infections, Lungs & breathing clinical trials.
This study tests two flu medicines, oseltamivir and baloxavir marboxil, to see if they can prevent flu in people who are in the hospital and were exposed to someone with the flu. It may help you avoid getting sick while you are in the hospital.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 12 years old (or 2 years old if you are the person with the flu).
- You must be a patient or a caregiver staying in a participating hospital.
- You must have been in the same room as a patient who tested positive for the flu within the last 3 days.
- You must be expected to stay in the hospital for at least 72 hours.
- You must have a negative flu test on the first day of the study.
- You must not have had the flu in the past 12 weeks or taken antiviral drugs in the past 2 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if taking suraxavir marboxil or oseltamivir can stop the flu from spreading to people sharing a hospital room with a patient who has the flu.
This trial tests whether two flu medicines—baloxavir and oseltamivir—work better to treat influenza in people with weakened immune systems (like transplant or blood cancer patients). It may help reduce severe complications, especially when flu affects the lungs or is at high risk to do so.
This study tests how well a single-dose flu treatment (baloxavir marboxil) works for children with the flu and whether it stops the flu from spreading to family members. If your child has early flu symptoms and lives with others, participation could help protect your household.
This study tests an investigational flu medicine (called Suraxavir Marboxil) for children with the flu. The goal is to see if it safely and effectively treats flu symptoms and shortens the illness.
This Phase 2 study compares antiviral medicines in adults who have early, flu-like symptoms and test positive for influenza. It aims to see which antiviral treatment works best and is safe for people treated soon after symptoms start.
This study tests a new antiviral pill, GP681, to prevent the flu in people who live with someone who has the flu. If you haven't gotten sick yet and are otherwise healthy, this might help keep you from catching it.
Hear when a new Influenza trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.